Ribociclib Tablets
200mg
Treats hormone receptor-positive HER2-negative breast cancer by inhibiting cyclin-dependent kinases 4 and 6 to halt cancer cell division and slow tumour growth.
From$20.87/ tabletView
Hormone Receptor-positive, Her2-negative Locally Advanced or Metastatic Breast Cancer in Combination with An Aromatase Inhibitor as Initial Endocrine-based Therapy
A selection of medicines used for Hormone Receptor-positive, Her2-negative Locally Advanced or Metastatic Breast Cancer in Combination with An Aromatase Inhibitor as Initial Endocrine-based Therapy is listed below, including Ribociclib. Products containing Ribociclib feature in this group. Prices and product details are shown for comparison.
Review product labelling and speak with a healthcare professional before treatment decisions.